Fig. 2From: Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort studyKaplan–Meier curve of PFS of patients with different AMC, ALB, PNI, and SIRI. PFS, progression-free survival; AMC, absolute monocyte count; ALB, albumin; PNI, prognostic nutritional index; SIRI, systemic inflammatory response indexBack to article page